| Product NDC: | 49884-501 |
| Proprietary Name: | Budesonide |
| Non Proprietary Name: | Budesonide |
| Active Ingredient(s): | 3 mg/1 & nbsp; Budesonide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49884-501 |
| Labeler Name: | Par Pharmaceutical Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021324 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20110818 |
| Package NDC: | 49884-501-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (49884-501-01) |
| NDC Code | 49884-501-01 |
| Proprietary Name | Budesonide |
| Package Description | 100 CAPSULE in 1 BOTTLE (49884-501-01) |
| Product NDC | 49884-501 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Budesonide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20110818 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Par Pharmaceutical Inc. |
| Substance Name | BUDESONIDE |
| Strength Number | 3 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |